GRDX (GRDX) Stock Analysis
Verdict: AVOID
Pre-revenue biotech pivot with sub-2-month cash runway faces imminent equity dilution risk and unsustainable capital burn.
Investment score: 16/100
GridAI Technologies Corp faces an extreme liquidity squeeze with under two months of cash runway remaining ($0.90M cash vs. -$5.70M operating cash burn in 2025). The model sees severe risk of equity dilution or restructuring.
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| TCRX | -0.39 | 0.67 | 3.07 | -0.11 | — | -16.55 |
| ACTU | -1.13 | 24.37 | 0.00 | -0.98 | — | 0.00 |
| ATOS | -0.56 | 0.81 | 0.00 | 0.05 | — | 0.00 |
| CLRB | -0.54 | 1.00 | 0.00 | 0.58 | — | 0.00 |
| LTRN | -1.11 | -6.94 | 0.00 | -0.88 | — | 0.00 |